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Abstract  
Background: Hypercholesterolemia-induced endothelial dysfunction due to excessive 
production of reactive oxygen species (ROS) is a major trigger of atherogenesis. The c-
Jun-N-terminal kinases (JNK) are activated by oxidative stress and play a key role in 
atherogenesis and inflammation. We investigated whether JNK2 deletion protects from 
hypercholesterolemia-induced endothelial dysfunction and oxidative stress. 
Methods and results: Male JNK2 knockout (JNK2-/-) and wild-type (WT) mice (8 weeks 
old) were fed either a high cholesterol (HCD; 1.25% total cholesterol) or a normal diet (ND) 
for 14 weeks. Aortic lysates of WT mice fed a HCD showed an increase in JNK 
phosphorylation compared with WT mice fed a ND (p<0.05). Endothelium-dependent 
relaxations to acetylcholine were impaired in WT HCD mice (p<0.05 vs. WT ND). In 
contrast, JNK2-/- HCD mice did not exhibit endothelial dysfunction (96±5% max relaxation 
to Ach, p<0.05 vs. WT HCD). Endothelium-independent relaxations were identical in all 
groups. Hypercholesterolemia-induced decrease in NO release of endothelial cells was 
found in WT but not in JNK2-/- mice. In parallel, eNOS expression was upregulated only in 
JNK2-/- HCD animals, whereas the expression of antioxidant defense systems such as EC-
SOD and Mn-SOD was decreased in WT, but not in JNK2-/- HCD mice. In contrast to 
JNK2-/- mice, WT HCD displayed an increase in O2- and ONOO- concentrations as well as 
of nitrotyrosine staining and peroxidation. 
Conclusions: JNK2 plays a critical role as a mediator of hypercholesterolemia-induced 
endothelial dysfunction and oxidative stress. Thus, JNK2 may provide a novel target for 
prevention of vascular disease and atherosclerosis. 
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Introduction 
 
Atherosclerosis is a systemic immunoinflammatory disease developing in response to 
endothelial injury (1). Indeed, the endothelium is a key determinant of vascular integrity. 
Hypercholesterolemia, a well-known risk factor for cardiovascular disease, leads to 
accumulation and oxidation of LDL-cholesterol within the intima of the vessel wall 
triggering endothelial dysfunction and pro-inflammatory milieu as crucial steps in the early 
phase of the atherosclerotic process (2). Oxidative stress, resulting from an imbalance 
between reactive oxygen species (ROS) and antioxidant defense system, is a crucial 
mediator of hypercholesterolemia-induced endothelial dysfunction (3,4). Indeed, ROS 
interact and inactivate nitric oxide (NO) and lead to protein nitration and lipid peroxidation. 
The c-Jun N-terminal kinases (JNKs), also known as stress-activated protein kinases 
(SAPK), are serin/threonin protein kinases belonging to the mitogen-activated protein 
kinase (MAPK) superfamily (5). JNKs play a fundamental role in stress responses, cell 
survival and apoptosis. The JNK pathway is activated by stress factors such as UV and 
radiation, reperfusion injury, ceramides, and inflammatory cytokines (6). The dimerization 
of JNK leads to activation of other kinases, their nuclear translocation and subsequent 
modulation of the activity of different transcription factors such as c-Jun, ATF-2, Elk-1, p-
53 and c-myc (7). 
Three distinct JNK genes have been described, JNK1, JNK2, and JNK3, encoding for 
different isoforms. JNK3 expression is restricted to brain, heart and testis, while JNK1 and 
JNK2 proteins are ubiquitously expressed (8). Both JNK1- and JNK2-deficient mice are 
viable indicating that neither JNK1 nor JNK2 play an essential role in development and 
normal cellular functions; however, genetic disruption of both JNK1 and JNK2 is lethal (9). 
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Studies using gene targeting as wells as JNK inhibitors demonstrated the involvement of 
JNK1 and JNK2 genes in several pathological conditions including cancer, immune and 
neurological diseases as well as metabolic disorders and inflammatory conditions such as 
arthritis and atherosclerosis (10). 
JNKs are expressed in vascular smooth muscle cells (VSMC) and endothelial cells (EC) 
and activated by a wide range of stimuli such as oxidative stress, mechanical stretch, 
hypertension (11-13), hyperglycemia, apoptosis (14) or inflammation (10). A recent study 
suggested a role of JNK in endothelial dysfunction: short-term exposure of coronary 
arterioles to TNFα-induced endothelial dysfunction through activation of JNK signal 
transduction pathway and generation of superoxide anion (15). We recently reported a 
critical role of JNK2 in atherogenesis showing that JNK2 is required for foam cell formation 
within the atherosclerotic plaque by activating the scavenger receptor A (SR-A) (16). 
The role of JNK2 in the early stage of atherosclerosis related to endothelial dysfunction as 
it occurs under hypercholesterolemic conditions remains unknown. Thus, we compared 
JNK2-deficient to wild-type mice exposed to a high cholesterol or a normal diet. We found 
that endogenous JNK2 is critically involved in hypercholesterolemia-induced endothelial 
dysfunction and oxidative stress. 
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Materials and Methods  
 
Animals and diets 
JNK2-/-
 
 and WT mice (both in a C57BL/6J background) were obtained from Jackson 
Laboratory (Bar Harbor, ME) and kept on a regular diet. Mice were housed in temperature-
controlled cages (20-22◦C), fed ad libitum and maintained on a12:12-hour light–dark cycle. 
At the age of 8 weeks, mice were fed a normal (ND) or a high cholesterol diet (HCD, 
D12108 containing 1.25% cholesterol, Research Diets, New Brunswick, NJ) for 14 weeks, 
respectively. All animal experiments were approved by the local Institutional Animal Care 
Committee  
Plasma lipid measurements 
At the time of tissue harvesting, 0.5 to 1 ml of blood was drawn from the right ventricle with 
heparinized syringes, immediately centrifuged at 4°C, and the plasma stored at -80°C. 
Total cholesterol, triglycerides, and free fatty acids were analyzed using the reagents 
TR13421, TR22421 (both Thermo Electron Clinical Chemistry & Automation Systems) and 
994-75409 (Wako Chemicals GmbH, Germany), as recommended by the manufacturer. 
The lipid distribution in plasma lipoprotein fractions was assessed by fast-performance 
liquid chromatography gel filtration with a Superose 6 HR 10/30 column (Pharmacia, 
Sweden). 
 
Tissue harvesting 
Mice were euthanized by intraperitoneal administration of 50 mg/kg sodium pentobarbital. 
The entire aorta from the heart to the iliac bifurcation was excised and placed immediately 
in cold modified Krebs-Ringer bicarbonate solution (pH 7.4, 37°C, 95% O2; 5% CO2) of 
the following composition (mmol/L): NaCl (118.6), KCl (4.7), CaCl2 (2.5), KH2PO4 (1.2), 
MgSO4 (1.2), NaHCO3 (25.1), glucose (11.1), and calcium EDTA (0.026). The aorta was 
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cleaned from adhering connective tissue under a dissection microscope, and either snap-
frozen in liquid nitrogen and stored at -80°C or used immediately for organ chamber 
experiments. 
 
Organ chamber experiments 
For endothelial function experiments, aortae were cut into rings (2 to 3 mm long). Each 
ring was connected to an isometric force transducer (Multi-Myograph 610M, Danish Myo 
Technology, Denmark), suspended in an organ chamber filled with 5 mL Krebs-Ringer 
bicarbonate solution (37°C, pH 7.4), and bubbled with 95% O2, 5% CO2. Isometric tension 
was recorded continuously. After a 30 minute equilibration period, rings were gradually 
stretched to the optimal point of their length–tension curve as determined by the 
contraction in response to potassium chloride (100 mmol). Concentration–response curves 
were obtained in a cumulative fashion. Several rings cut from the same artery were 
studied in parallel. Responses to acetylcholine (Ach, 10-9 to 10-6 mol/L, Sigma Aldrich) in 
the presence or absence of polyethylene glycol-superoxide dismutase (PEG-SOD, 150 
U/ml, Sigma Aldrich) were recorded during submaximal contraction to norepinephrine (NE, 
10-6 mol/L). The NO donor sodium nitroprusside (SNP, 10-10 to 10-5 mol/L, Sigma Aldrich) 
was added to test endothelium-independent relaxation. Relaxations were expressed as a 
percentage of the precontracted tension. 
Measurements of NO, O2- and ONOO-
Concurrent measurements of NO, O
   
2
- and ONOO- were carried out with three 
electrochemical nanosensors combined into one working unit with a total diameter of 2.0 - 
2.5 µm. Their design was based on previously developed and well-characterized 
chemically modified carbon-fiber technology (4,17,18). Amperometry was performed with a 
computer-based Gamry VFP600 multichannel potentiostat. A current at the peak potential 
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characteristic for NO (0.65 V) oxidation and ONOO- (-0.40 V) or O2- (-0.23 V) reduction 
was directly proportional to the local concentrations of these compounds in the immediate 
vicinity of the sensor. Linear calibration curves (current vs. concentration) were 
constructed for each sensor from 10 nmol/L to 2 µmol/L before and after measurements 
with aliquots of NO, O2- and ONOO- standard solutions, respectively. At a constant 
distance of the sensors from the surface of the endothelial cell, the reproducibility of 
measurements is high (5-12%). The consumption of redox species by nanosensors 
depends on the area of the electrode (< 0.12 µm2) and the duration time of electrolysis 
(~5-10 s). For the amperometric measurements used, it varied between 0.04-0.1% of the 
NO, O2-and ONOO-
Western blotting 
 peak concentration. This value is negligible compared with the 
experimental error. The position of nanosensors (x,y, z coordinates) versus the endothelial 
cell was established with the help of a computer controlled micromanipulator. In order to 
establish a constant distance from cells, the module of sensors was lowered until it 
reached the surface of the cell membrane. After that, the sensors were slowly raised 4 + 1 
µm (z coordinates) from the surface of cells. The sensors were then moved horizontally (x, 
y coordinates) and positioned above a surface of randomly chosen single endothelial cells 
in an aortic ring. Acetylcholine (Ach), were then injected with a nanoinjector that was also 
positioned by a computer controlled-micromanipulator. 
Frozen samples of aortae were pulverized and dissolved in lysis buffer (120 mmol/L 
sodium chloride, 50 mmol/L Tris, 20 mmol/L sodium fluoride, 1 mmol/L benzamidine, 1 
mmol/L DTT, 1 mmol/L EDTA, 6 mmol/L EGTA, 15 mmol/L sodium pyrophosphate, 0.8 
µg/mL leupeptin, 30 mmol/L p-nitrophenyl phosphate, 0.1 mmol/L PMSF, and 1% NP-40) 
for immunoblotting. Cell debris were removed by centrifugation (12 000 g) for 10 minutes 
at 4°C. The samples (20 µg) were treated with 5x Laemmli’s SDS-PAGE sample buffer 
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(0.35 mol/L Tris-Cl, pH 6.8, 15% SDS, 56.5% glycerol, 0.0075% bromophenol blue), 
followed by heating at 99°C for 5 minutes, and then subjected to 10% SDS-PAGE gel for 
electrophoresis. The proteins were then transferred onto Immobilon-P filter papers 
(Millipore AG, Bedford, MA) with a semidry transfer unit (Hoefer Scientific, San Francisco, 
CA). The membranes were then blocked by use of 5% skim milk in TBS-Tween buffer 
(0.1% Tween 20; pH 7.5) for 1 hour at room temperature and incubated with anti total JNK 
and p-JNK; (1:1000, Santa Cruz Biotechnology, Inc), anti-NOS3 rabbit polyclonal antibody 
(1:1000 dilution; Santa Cruz Biotechnology, Inc), anti-phospho (Ser1177) –eNOS rabbit 
polyclonal antibody (1:250, Cell Signaling), anti-MnSOD rabbit polyclonal antibody (1:2000 
dilution, Upstate USA, Inc), anti-Cu/ZnSOD rabbit polyclonal antibody (1:2000; Upstate 
Biotechnology) and anti-ECSOD (1:1000; Upstate Biotechnology) for 1 hour at room 
temperature. Membranes were then incubated with the secondary antibody (horseradish 
peroxidase–conjugated anti-mouse/rabbit immunoglobulin antibody; Amersham Pharmacia 
Biotech) at a dilution of 1:2000. Prestained markers (Bio-Rad Laboratories) were used for 
molecular mass determinations. The immunoreactive bands were detected by an 
enhanced chemiluminescence kit (Amersham Biosciences). 
Immunohistochemistry and superoxide detection  
Anti-α-tubulin mouse 
monoclonal antibody (1:2000) or anti-β−actin (1:1000, Sigma Aldrich) was employed as a 
loading control. Western blots were quantified densitometrically (NIH Image 1.6, Bethesda, 
MD).  
 
Freshly isolated aortic segments were immediately embedded in O.C.T. medium and snap 
frozen in pentane/liquid nitrogen. Cryosections of 6 µm thickness were mounted on 
SuperFrost glass slides and incubated at 37°C for 30 min with 1 µM dihydroethidium for 
superoxide detection. In order to stain for protein-bound nitrotyrosine or MnSOD, sections 
were fixed in 4% PBS-buffered formalin for 5 min, blocked with 10% BSA in PBS and 
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incubated with polyclonal anti-nitrotyrosine antibody (1:50; Upstate) and anti-MnSOD 
antibody (1:250; StressGen) at 4°C overnight, respectively. For visualization, the 
secondary antibody (Alexa568 anti-rabbit IgG; 1:300; Molecular Probes) was incubated for 
1h at room temperature. Slides were then rinsed, embedded in glycerin-PBS and 
examined under a fluorescent microscope (DM-IRB; Leica) connected to a digital imaging 
system (Spot-RT; Diagnostic Instruments/Visitron Systems, Germany). Pictures were 
obtained using identical camera and microscope settings. Dihydroethidium-stained 
specimens were background-corrected for autofluorescence of elastic fibers and the basal 
lamina using ImageJ/ NIH (rsb.info.nih.gov/ij/). 
 
Thiobarbituric acid reactive substances (TBARS) assay 
In vitro assessment of aortic levels of lipid peroxidation was performed using TBARS 
Assay Kit (OXItek, ZeptoMetrix, New York), according to the manufacturer’s instructions. 
Briefly, snap frozen tissue was crushed in a pre-chilled mortar and pestle and 
resuspended at a concentration of 50 mg/ml in PBS. 100 µl of homogenate were then 
added to SDS solution and thoroughly mixed. Following TBA/buffer reagent addition, 
samples were incubated at 95º
Statistical analysis 
C for 60 minutes and centrifuged at 3000 rpm at room 
temperature for 15 minutes. Absorbance was read at 532 nm. 
 
Results are expressed as mean±SEM and n indicates number of experiments. Statistical 
analysis was performed with Student’s t test for simple comparisons between 2 values. For 
multiple comparisons results were analyzed by ANOVA followed by Bonferroni post-hoc 
correction. A value of p<0.05 was considered statistically significant.  
The authors had full access to and take full responsibility for the integrity of the data. All 
authors have read and agree to the manuscript as written. 
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Results 
 
Lipid profiles 
We determined plasma cholesterol, triglycerides and free fatty acids in JNK2-/- and WT 
mice fed either a HCD or a ND (Table 1). Both JNK2-/- and WT mice developed significant 
hypercholesterolemia after 14 weeks of HCD. Interestingly, JNK2-/-
Isometric tension studies demonstrated no difference in vascular contractions to 
norepinephrine (NE) between aortae obtained from WT or JNK2
 mice had slight but 
significantly increased levels of total plasma cholesterol compared with WT mice either on 
ND or HCD (Table 1). No difference in plasma triglycerides or free fatty acids was 
observed between the groups (Table 1). 
 
Hypercholesterolemia activates aortic JNK  
To determine the effect of hypercholesterolemia on JNK activation, we compared Western 
blot analyses of aortic lysates from normo- and hypercholesterolemic WT mice using a 
phosphospecific JNK antibody. Aortae from WT mice on HCD showed increased JNK 
phosporylation compared with vessels from WT on ND (Figure 1).  
 
JNK2 deletion protects from hypercholesterolemia-induced endothelial dysfunction 
-/- mice fed either a HCD or 
ND (data not shown). Endothelium-dependent relaxations to acetylcholine were impaired 
in WT mice on HCD compared with WT mice on ND. Interestingly, endothelium-dependent 
relaxations remained normal in JNK2-/- HCD mice, suggesting a preserved •NO 
bioavailability favored by the lack of JNK2 (Figure 2A). Concurrent with this notion, 
addition of the free radical scavenger PEG-SOD (150U/mL) significantly improved 
endothelium-dependent relaxations in HCD WT mice (Figure 2B). Endothelium-
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independent relaxations to sodium nitroprusside were similar in all groups (data not 
shown).  
 
Preserved endothelial NO release in hypercholesterolemic JNK2-/-
For assessing NO bioavailability at the level of endothelial cells, we determined NO in 
single endothelial cells using nanonsensors. After stimulation with acetylcholine (10
 mice   
-7 
mol/L), maximal NO levels were 242+10 nmol/L in WT mice on ND, and decreased about 
50% in WT mice on HCD (Figure 3A). In contrast, similar levels of NO release were found 
in JNK2-/-
Decreased oxidative stress in hypercholesterolemic JNK2
 mice on ND or HCD (Figure 3A).  
 
-/-
To determine the effect of hypercholesterolemia on oxidative stress in endothelial cells, we 
measured superoxide anion (O
 mice 
2
-) and peroxynitrite (ONOO-) production in single aortic 
endothelial cells. A significant increase in O2- concentration was observed in WT mice 
exposed to HCD compared with WT mice on a ND, whereas no significant 
hypercholesterolemia-induced changes were observed in JNK2-/- mice (Figure 3B and C). 
In agreement with preserved NO bioavailability and O2- findings, ONOO- concentrations 
were increased only in WT, but not in JNK2-/- mice fed a HCD (Figure 4A). Since ONOO- 
leads to increased 3-nitrotyrosine-containing proteins, we performed in situ 
immunohistochemistry with a polyclonal antibody against 3-nitrotyrosine in aortic cross-
sections. JNK2-/- HCD mice showed a markedly reduced immunoreactivity both in the 
endothelium and in the media compared with diet-matched WT mice (Figure 4B). This 
favourable redox profile was confirmed measuring aortic TBARS levels. Following HCD 
exposure, JNK2-/- mice did not exhibit an increase in lipid peroxidation compared with WT 
mice (Figure 4C).  
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Free radical scavenger expression and activity 
Protein expression of three pivotal free radical scavengers was assessed to determine 
whether an upregulation of antioxidant defense mechanisms might explain the preserved 
NO bioavailability in hypercholesterolemic JNK2-/- mice. Cu/Zn-SOD was similar in all 
experimental groups (data not shown), whereas aortic expression of manganese (Mn) and 
extracellular (EC) SOD was significantly decreased in WT mice fed a HCD compared with 
WT mice on a ND (Figure 5A and B). By contrast, levels of Mn-SOD and EC-SOD in JNK2-
/- HCD were similar to WT ND mice (Figures 5A and B). Unexpectedly, JNK2-/-
Increased eNOS expression in JNK2
 ND 
exhibited a reduced expression of both SOD isoforms compared with diet-matched WT 
mice (Figures 5A and B). Accordingly, immunofluorescent stainings for MnSOD showed 
similar results in aortic cross-sections (Figure 5C). 
 
-/-
In order to get more insight into the mechanisms of preserved NO bioavailability in JNK2
 mice 
-/- 
mice with hypercholesterolemia, we quantified eNOS expression in aortic lysates. eNOS 
expression was not affected by HCD in WT mice, whereas JNK2-/- HCD mice showed a 
significant increased expression of eNOS (Figure 6A). Furthermore, to determine whether 
NO production was also regulated by eNOS activity, we performed additional blotting of 
phosphorylated Ser1177-eNOS in pooled samples. pS1177-eNOS protein levels were 
similar in aortic lysates from JNK2-/- on either diet and WT mice on ND. In contrast, we 
found reduced eNOS phosphorylation in WT mice on HCD (Figure 6B). 
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Discussion  
 
This study for the first time demonstrates that genetic deletion of JNK2 protects against 
hypercholesterolemia-induced and ROS-mediated endothelial dysfunction. The following 
findings support our conclusion: 1) Chronic exposure of WT mice to a high cholesterol diet 
induces aortic JNK phosphorylation. 2) In contrast to WT mice, long-term exposure of 
JNK2-/- to HCD did not impair endothelium-dependent relaxation to acetylcholine. 3) Lower 
ONOO- levels in hypercholesterolemic JNK2-/- mice were associated with decreased 
protein nitration and lipid peroxidation. Accordingly, 4) expression of the antioxidant 
enzymes Mn-SOD and EC-SOD was increased in JNK2-/- mice. In contrast, we observed a 
downregulation of these enzymes after 14 weeks of HCD in WT mice.  
Genetic deletion of JNK2 did not affect severity of hypercholesterolemia, although JNK2-/- 
mice had slightly but significantly increased levels of total cholesterol compared with WT 
mice either fed with normal or high cholesterol diet. Thus, we could rule out that 
differences observed among the two groups were caused by different experimental 
conditions. In contrast to our findings, a recent study showed similar total plasma 
cholesterol levels in JNK2-/-
Preserved bioavailability of NO is a key marker of vascular integrity. In vivo, activity of the 
L-arginine-NO pathway is determined by a balance between synthesis and breakdown of 
NO for its reaction with O
 and WT controls (19). 
2
-. This balance is impaired in hypercholesterolemia and 
atherosclerosis (20,21). Endothelial dysfunction, reflected by impaired endothelium-
dependent relaxation, occurs in experimental models of hypercholesterolemia as was 
confirmed in wild-type mice of this study (22,23). Similarly, many clinical studies reported 
abnormal endothelium-dependent vasodilation in hypercholesterolemic patients (24). 
Hypercholesterolemia induces a series of molecular events that increase the production of 
ROS and inactivate NO to form ONOO- (25). In this study, acetylcholine-induced relaxation 
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did not differ between JNK2-/- and WT mice in control conditions of normocholesterolemia 
following normal diet. However, upon chronic hypercholesterolemia induced by 14 weeks 
of HCD, WT mice but not JNK2-/- mice developed endothelial dysfunction.  
The finding that addition of the free radical scavenger PEG-SOD restored endothelium-
dependent relaxation in wild-type mice on a high cholesterol diet suggests an important 
role of reactive oxygen species in this context. Hypercholesterolemia-induced oxidative 
stress has been attributed to activation of oxidases in the vasculature and in infiltrating 
leukocytes (22). Moreover, hypercholesterolemia has been shown to impair antioxidant 
defense mechanisms against ONOO- formation (25). 
To investigate whether preserved endothelial function in hypercholesterolemic JNK2-/- 
mice was associated with increased bioavailability of NO, we assessed NO release from 
single endothelial cells after stimulation with acetylcholine. In hypercholesterolemic control  
mice, NO levels decreased by about 50%, whereas they remained unchanged in JNK2-/- 
mice. Because O2- is the main inactivator of NO, we tested whether decreased endothelial 
production of O2- contributes to increased •NO bioavailability in JNK2-/- mice. We found 
enhanced O2- production in hypercholesterolemic wild-type mice compared with mice on a 
normal diet, whereas no significant diet-induced changes were detected in JNK2-/-
In aortae exposed to chronic hypercholesterolemia, the reaction of NO and O
 mice. 
Dihydroethidium stainings of aortic segments confirmed these findings. 
2
- leads to 
enhanced ONOO- formation, and in turn, increased nitrotyrosine residues which are typical 
end products of the reaction of ONOO- with biological compounds (26). Tyrosine nitration 
is responsible for inactivation of several enzymes (27). Our group has shown that nitration 
of MnSOD and prostacyclin synthase occur in aged and diabetic mice, respectively 
(28,29). In agreement with the notion that JNK2 deficiency induces preserved NO 
bioavailability, but reduced O2- production, we found that ONOO- concentrations were 
increased in WT, but not in JNK2-/- mice fed a HCD. In parallel, nitrotyrosine 
 15 
immunoreactivity was detected in both endothelium and smooth muscle cells of 
hypercholesterolemic mice, as previously shown by our group (30). However, aortae from 
hypercholesterolemic wild-type mice exhibited enhanced immunostaining compared with 
diet-matched JNK2-/- mice. ONOO- contributes to atherogenesis by promoting lipid 
peroxidation (31). In contrast to hypercholesterolemic wild-type mice, JNK2-/-
To investigate whether antioxidant defense mechanisms contribute to the preserved 
endothelial function in hypercholesterolemic JNK2
 mice were 
protected against lipid peroxidation as determined by TBARS in aortic lysates. 
-/- mice, we assessed protein expression 
of three pivotal O2- scavengers. Aortic expression of Mn-SOD and EC-SOD was 
decreased in hypercholesterolemic wild-type mice as compared to normocholesterolemic 
controls. By contrast, both Mn-SOD and EC-SOD were induced after 14 weeks of 
hypercholesterolemia in JNK2-/- mice. Furthermore, in situ immunohistochemistry showed 
that changes in MnSOD expression occur throughout the aortic vascular wall. These 
findings suggest that the ability of the SOD scavenging system to respond to oxidative 
stress remains intact in JNK2-/- mice. Unexpectedly, normocholesterolemic JNK2-/- mice 
exhibited a reduced expression of Mn-SOD and EC-SOD compared with diet-matched WT 
mice. However, these changes did not translate into differences in endothelium-
dependent, NO-mediated responses as shown by organ chamber experiments and in situ 
measurements of NO release. At low concentrations, O2- diffusion is slow and O2- is 
scavenged by highly diffusible NO. Therefore, at low O2- in JNK2-/- mice on ND, SOD may 
be less competitive for O2- than NO. This process may change under high O2- and low NO 
levels as found in the context of hypercholesterolemia where the role of SOD becomes 
more substantial. Accordingly, the reduced expression of Mn-SOD and EC-SOD in JNK2-/- 
mice on ND did not translate into changes of NO, O2- and ONOO- production. In order to 
get more insight into the mechanisms of preserved NO bioavailability in 
hypercholesterolemic JNK2-/- mice, we assessed eNOS expression in aortic lysates. 
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Western blot analysis revealed higher eNOS expression in hypercholesterolemic JNK2-/- 
compared with wild-type mice. Conflicting data have been reported related to the 
regulation of eNOS during hypercholesterolemia. There is evidence of reduced 
transcription and enhanced breakdown of eNOS transcripts upon increasing 
concentrations of oxidized LDL. Long-term stimulation with oxidized LDL may also lead to 
a decrease in the amount of NOS protein through induction of cytokines (32). Experimental 
atherosclerosis is associated with an increased eNOS expression and NO production, 
whereas decreased eNOS expression and NO release is found in advanced human 
atherosclerosis (33). To determine whether NO production was also regulated by eNOS 
activity, we determined eNOS phosphorylation. Interestingly, the observed upregulation of 
eNOS protein in JNK2-/- on HCD did not translate into increased eNOS phosphorylation, 
justifying unchanged NO concentrations and endothelium-dependent relaxations  in JNK2-
/-
As deletion of JNK2 in hypercholesterolemic mice was associated with upregulation of 
SOD, it is likely that this antioxidant defense system contributes to protect against 
hypercholesterolemia-mediated oxidative stress in JNK2
 mice. On the other hand, decreased eNOS phosphorylation in WT HCD mice matched 
reduced NO levels found in this group  
-/- mice. Thus, our findings 
suggest that JNK2 is involved in the pathways regulating vascular endothelial ROS 
production and antioxidant defense systems under hypercholesterolemic conditions. Our 
results are in accordance with previous studies that associate JNK activation with 
increased levels of oxidative stress and ROS-mediated cell death (34). In particular, JNK is 
known to play a major role in cardiovascular disease and is activated upon mechanical 
stress, hypertension (11-13) and ischemia/reperfusion (35). JNK has also been reported to 
be activated in advanced atherosclerotic plaques in rabbits as well as in humans (34) and 
to activate matrix proteases involved in disease progression of abdominal aortic aneurysm 
in mice and humans (36). Along this line, JNK2 is necessary for scavenger receptor A or 
 17 
CD36-mediated foam cell formation in atherogenesis (16,37,38). JNK2 has also been 
demonstrated to be involved in insulitis of type I diabetes mellitus (39). Pharmacologic JNK 
inhibition is a promising strategy given its beneficial effects in mouse models of 
atherogenesis (16), abdominal aneurysm (37), and cerebral ischemia (40). JNK inhibition 
may even be more rewarding considering its the critical role in obesity and insulin 
resistance (41). Thus, JNK inhibition could
 
 
represent a attractive therapeutic target to 
prevent progression of atherosclerosis and metabolic disease. Our findings suggest that 
JNK may also be a promising target for preventing atherosclerosis at its early stage of 
endothelial dysfunction. 
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Figure Legends 
 
Figure 1. Representative Western blots show phosphorylated JNK (p-JNK) protein 
expression in aortic lysates from wild-type (WT) after 14 weeks of normal (ND) 
or high cholesterol diet (HCD). Expression of total JNK was used as a loading 
control. 
 
Figure 2. (A) Hypercholesterolemia-induced changes in endothelium-dependent 
relaxation of aortae isolated from WT and JNK2-deficient (JNK2-/-) mice after 
14 weeks of normal (ND) or high cholesterol diet (HCD). Line graphs show 
concentration–response curves to acetylcholine (Ach) during submaximal 
contraction to norepinephrine (10-6 mol/L). (B) Effect of polyethylene glycol-
superoxide dismutase (PEG-SOD) on the endothelium-dependent relaxation to 
acetylcholine in all experimental groups. Results are presented as mean±SEM; 
n=4-6 in each group. *p < 0.05 for WT HCD vs. all other groups. 
 
Figure 3. Bar graphs show the concentration of (A) nitric oxide (NO) and (B) superoxide 
(O2-) produced by a single aortic endothelial cell of WT and JNK2-/- mice after 
14 weeks of normal (ND) or high cholesterol diet (HCD). Peak concentrations 
were measured after stimulation with acetylcholine (10-7 mol/L). Results are 
presented as mean±SEM; n=4-6 in each group; *p < 0.05 vs. WT ND. (C) 
Similar results were obtained by fluorescence detection of O2- (red 
dihydroethidium staining) in freshly isolated aortic segments of WT and  JNK2-
/-
 
 mice after ND or HCD, respectively. 
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Figure 4. (A) Bar graphs show peroxynitrite (ONOO-) concentration produced by a 
single aortic endothelial cell of WT and JNK2-/- mice after 14 weeks of normal 
(ND) or high cholesterol diet (HCD). ONOO- was measured simultaneously 
with NO and O2- after stimulation with acetycholine (10-7 mol/L).   (B) In 
aortae of WT and JNK2-/- mice after ND or HCD, immunostaining for 
nitrotyrosine (red staining) was detected both in the endothelium and in the 
media. (C) Bar graphs show TBARS levels in aortae of WT and JNK2-/- mice 
after ND or HCD, respectively. Results are presented as mean±SEM; n=4-6 
in each group, *p< 0.05 vs WT ND. 
 
Figure 5. Mn-SOD (A) and EC-SOD (B) protein expression from aortae of WT and 
JNK2-/- mice after 14 weeks of normal (ND) or high cholesterol diet (HCD). 
Representative Western blots and densitometric quantification are shown. 
Results are presented as mean±SEM of Mn-SOD and EC-SOD/α-Tubulin 
expression ratio, n=4-6 in each group. *p< 0.05 vs. ND WT, **p<0.05 vs. 
JNK2-/- ND,  †p<0.05 vs. diet-matched WT. ).   (C) In aortae of WT and JNK2-
/-
Figure 6. eNOS protein expression and phosphorylation in aortic lysates from WT and JNK2
 mice after ND or HCD, immunostaining for MnSOD (red staining) was 
detected both in the endothelium and in the media. 
 
-/- 
mice after 14 weeks of normal (ND) or high cholesterol diet (HCD).  (A) 
Representative Western blot and densitometric quantifications are shown for eNOS 
expression. Results are presented as mean±SEM of eNOS/α-Tubulin expression 
ratio, n=4-6 in each group. *p< 0.05 for JNK2-/- HCD vs. all other groups. (B) 
Western blot of eNOS phosphorylation (pooled samples of n=3 mice in each group) 
using β−actin as a loading control. 
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Table 1. Plasma lipids from JNK2-/- and WT littermates after 14 weeks of normal diet (ND) 
or high cholesterol diet (HCD). 
 
 WD JNK2-/- 
 ND HCD ND HCD 
Total cholesterol (mmol/L) 3.3 ± 0.2 7.1 ± 2.4* 3.9 ± 0.3** 9.6 ±1.2*† 
Triglycerides (mmol/L) 1.34 ± 0.45 0.79 ± 0.18 1.40 ± 0.6 1.35 ± 0.27 
Free fatty acid (mmol/L) 0.54 ± 0.34 0.33 ± 0.07 0.35 ± 0.05 0.34 ± 0.09 
Values are mean ± SEM. n=4-6 in each group. *p<0.05 vs ND WT and JNK2-/- mice, 
respectively, *p<0.05 vs diet-matched WT, †p<0.05 vs. HCD WT mice. 
 
 
 
 
